Suchergebnisse - "Hashimoto, Takafumi"

PubPharm (66)

1

Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease : a post-hoc subgroup analysis of Japanese phase 3 randomized studies

enthalten in: Clinical and experimental nephrology | 2024

von Nangaku, M. | Ueta, K. | Nishimura, K. | +2

2

Enhanced Ca²⁺Binding to EF-Hands through Phosphorylation of Conserved Serine Residues Activates MpRBOHB and Chitin-Triggered ROS Production

enthalten in: bioRxiv.org | 2024

von Hashimoto, T. | Hashimoto, K. | Shindo, H. | +4

3

Factors affecting responsiveness of vadadustat in patients with anemia associated with chronic kidney disease: a post-hoc subgroup analysis of Japanese phase 3 randomized studies

enthalten in: Clinical and experimental nephrology | 2024

von Nangaku, M. | Ueta, K. | Nishimura, K. | +2

4

Enhanced Ca2+ binding to EF-hands through phosphorylation of conserved serine residues activates MpRBOHB and chitin-triggered ROS production

enthalten in: Physiologia plantarum | 2023

von Hashimoto, T. | Hashimoto, K. | Shindo, H. | +4

5

Giant benign intrathoracic schwannoma : a decade-long progression towards fatality

enthalten in: Journal of cardiothoracic surgery | 2023

von Miyawaki, M. | Karashima, T. | Abe, M. | +5

6

Osimertinib as first-line treatment for recurrent lung cancer patients with EGFR mutation

enthalten in: Journal of thoracic disease | 2023

von Osoegawa, A. | Karashima, T. | Takumi, Y. | +4

7

Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation

enthalten in: Thoracic cancer | 2023

von Osoegawa, A. | Abe, M. | Takumi, Y. | +4

8

Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations

enthalten in: Investigational new drugs | 2023

von Osoegawa, A. | Takumi, Y. | Hashimoto, T. | +7

9

Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations

enthalten in: Investigational new drugs | 2023

von Osoegawa, A. | Takumi, Y. | Hashimoto, T. | +7

10

Cyclin-dependent kinase (CDK) 4/6 inhibition in non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutations

enthalten in: Investigational new drugs | 2023

von Osoegawa, A. | Takumi, Y. | Hashimoto, T. | +7

1
2
3
4
5
6
7
Nächster »
[7]